Eubel Brady & Suttman Asset Management Inc Merck & Co., Inc. Transaction History

Eubel Brady & Suttman Asset Management Inc

$786 Million
Q1 2024

A detailed history of Eubel Brady & Suttman Asset Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Eubel Brady & Suttman Asset Management Inc holds 4,763 shares of MRK stock, worth $602,281. This represents 0.08% of its overall portfolio holdings.

Number of Shares

4,763

Previous 4,758 0.11%

Holding current value

$602,281

Previous $519,000 21.0%

% of portfolio

0.08%

Previous 0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$113.24 - $131.95 $566 - $659	5 Added 0.11%	4,763 $628,000
Q4 2023 Feb 12, 2024	BUY	$100.18 - $109.02 $10,619 - $11,556	106 Added 2.28%	4,758 $519,000
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $10,809 - $12,004	105 Added 2.31%	4,652 $479,000
Q2 2023 Aug 25, 2023	BUY	$108.61 - $118.38 $434 - $473	4 Added 0.09%	4,547 $525,000
Q1 2023 May 09, 2023	BUY	$102.94 - $114.86 $3,088 - $3,445	30 Added 0.66%	4,543 $483,000

Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $524 - $672	6 Added 0.13%	4,513 $501,000
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $422 - $474	5 Added 0.11%	4,507 $388,000
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $500 - $567	6 Added 0.13%	4,502 $410,000
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $441 - $494	6 Added 0.13%	4,496 $368,000
Q4 2021 Feb 10, 2022	BUY	$72.28 - $90.54 $722 - $905	10 Added 0.22%	4,490 $344,000
Q3 2021 Nov 05, 2021	SELL	$71.68 - $78.83 $20,930 - $23,018	-292 Reduced 6.12%	4,480 $336,000
Q2 2021 Aug 17, 2021	SELL	$70.31 - $77.77 $335,519 - $371,118	-4,772 Reduced 50.0%	4,772 $368,000
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $408,546 - $481,225	5,933 Added 164.3%	9,544 $736,000
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $73 - $82	1 Added 0.03%	3,611 $299,000
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $7,253 - $8,253	103 Added 2.94%	3,610 $279,000
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $253 - $351	4 Added 0.11%	3,507 $270,000
Q4 2019 Feb 11, 2020	BUY	$77.58 - $87.54 $232 - $262	3 Added 0.09%	3,503 $319,000
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $228 - $248	3 Added 0.09%	3,500 $295,000
Q2 2019 Aug 12, 2019	BUY	$69.84 - $81.59 $279 - $326	4 Added 0.11%	3,497 $293,000
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $208 - $238	3 Added 0.09%	3,493 $291,000
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $195 - $227	3 Added 0.09%	3,490 $267,000
Q3 2018 Nov 15, 2018	BUY	$57.69 - $67.84 $230 - $271	4 Added 0.11%	3,487 $247,000
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $17,587 - $20,663	-346 Reduced 9.04%	3,483 $211,000
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $203 - $236	4 Added 0.1%	3,829 $209,000
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $206 - $246	4 Added 0.1%	3,825 $215,000
Q3 2017 Nov 14, 2017	SELL	$58.67 - $63.13 $4,634 - $4,987	-79 Reduced 2.03%	3,821 $245,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,900	3,900 $250,000

Others Institutions Holding MRK

# of Institutions

3,769

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $320B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eubel Brady & Suttman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eubel Brady & Suttman Asset Management Inc with notifications on news.

Account

Eubel Brady & Suttman Asset Management Inc Merck & Co., Inc. Transaction History